Investing Profile

Anja Konig

VCInvestor
Global Head Novartis Venture Fund
nvfund.comBasel, Switzerland
Photo of Anja Konig, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
16
$750M
CompanyStageDateRound SizeTotal Raised
Forendo Pharma
Series UnknownJul 2019$6M
Series UnknownSep 2018$5M
Series AOct 2014$15M
$26M
Co-investors: Hakan Goker (M Ventures (Merck))
Bicycle Therapeutics
Series BJun 2017$52M
Series AOct 2014$32M
Series UnknownDec 2012$6M
SeedOct 2009
$90M
Co-investors: Deborah Harland (SR One), Bruce Booth (Atlas Venture), Dr. Regina Hodits (Wellington Partners)
F2G
Private EquityJun 2016$60M
Series UnknownSep 2012$30M
$160M
Co-investors: Maha Katabi (Sofinnova Investments), Raj Parekh (Advent Life Sciences), Nanna Luneborg (Forbion), Joseph Anderson (Soffinova Partners)
Nabriva Therapeutics
Series BApr 2015$120M
$120M
Covagen
Series BDec 2013$66M
Series ANov 2010$6M
SeedOct 2009
$72M
Co-investors: Abraham Kometz (Deerfield Management)
Oxagen
Series CNov 2009$27M
$27M
PharmAbcine
Series ASep 2009$6M
$6M
Diagnoplex
Series ADec 2008$8M
$9M
Co-investors: Thomas Goebel (Omega Funds)